Strides Pharma Science (Strides) through Strides Pharma Global, Singapore has received USFDA approval for its drug Triamcinolone Acetonide to market the same in US markets. The product is a generic version of Triamcinolone Acetonide cream of Mylan Pharmaceuticals.
According to market estimates, US market for Triamcinolone Acetonide cream is approximately US$ 55 million. The company will manufacture the product at its Bangalore production facility.
Company Profile : Strides Arcolab Ltd
Leave a Reply